Reply to R. Olofsson Bagge et al and G. Karakousis et al
- 20 September 2020
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 38 (27), 3235-3237
- https://doi.org/10.1200/jco.20.01832
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Systemic Therapy for Melanoma: ASCO GuidelineJournal of Clinical Oncology, 2020
- Overestimation of Risk for Sentinel Lymph Node Metastasis in a Nomogram for T1 MelanomasJournal of Clinical Oncology, 2020
- Comment on “Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram”Journal of Clinical Oncology, 2020
- Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and CostAnnals of Surgical Oncology, 2020
- Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive NomogramJournal of Clinical Oncology, 2020
- Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2018
- Transected thin melanoma: Implications for sentinel lymph node stagingJournal of Surgical Oncology, 2017
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingJournal of the Royal Statistical Society: Series B (Methodological), 1995